Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Ed Ajootian who wrote (4262)	3/9/2000 12:14:00 PM
From: Don Miller	Read Replies (2) \| Respond to of 10280

I would also speculate that the authors of all those papers were not 100% Sepracor. Therefore the company could not claim authorship, and was better served by getting multiple third party opinions in the public domain. I agree 100% that our drugs need exposure, it is merely a question of how that should best be done. 15 papers seems to me to be a very significant number of papers for one conference. That many papers alone says a lot to this layman. What we really need to refuel our stock price is that FTC OK.